Today: 7 February 2026
Subscribe

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Market Selloff Fueled by Loan Fraud Fears Wall Street skidded into the red late this week as fear of hidden loan losses gripped the market. On Thursday (Oct. 16), the Dow, S&P 500, and Nasdaq all closed sharply lower – around 0.5%–1% down each for the day reuters.com – after early gains evaporated. The Dow Jones index gave up roughly 300–400 points, about 0.65%, by the closing bell reuters.com. The reversal came suddenly after midday news of loan problems at two regional banks hit traders’ screens. “Signs of weakness in regional banks spooked investors already on edge,” Reuters noted, especially
17 October 2025
IBPS SO Prelims Result 2025 Out: 1000+ Bank Vacancies & Experts Bullish on Bank Stocks

IBPS SO Prelims Result 2025 Out: 1000+ Bank Vacancies & Experts Bullish on Bank Stocks

IBPS SO Prelims Results Released on IBPS Portal The IBPS has officially released the Specialist Officer (SO) Preliminary Exam 2025 results on its website, bringing relief and closure to thousands of candidates who took the test. The results went live on October 17, 2025, and applicants can now log in to the IBPS portal (ibps.in) to view their statusmoneycontrol.com. To access the score, candidates must enter their Registration/Roll Number and Password or Date of Birth, along with a captcha codetimesofindia.indiatimes.com. The result page shows key personal details (name, roll number, category, etc.) and whether the candidate has qualified for the
17 October 2025
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

In summary, Artiva Biotherapeutics stock has erupted in October 2025 on the back of a major FDA Fast Track win and renewed optimism around its NK-cell therapy for RA. The latest developments – from surging share price and volume to analyst projections of multi-fold upside – underscore the high stakes and high hopes riding on AlloNK’s success. For biotech investors and observers, ARTV will be a stock to watch closely in the coming months, as upcoming trial data and FDA feedback chart the next chapter for this promising yet still speculative biotech play. Latest Stock Price and Trend Analysis 247marketnews.com
17 October 2025
·
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Earnings Beat Sparks Relief Rally Truist’s third-quarter results breezed past expectations, providing a jolt of good news for the regional banking sector. Net income available to common shareholders came in at $1.35 billion (EPS $1.04), exceeding analysts’ $0.99 forecast investing.com and slightly above $0.99 in the prior-year quarter. Revenue of $5.24 billion (taxable-equivalent) was roughly in line with estimates investing.com, as strong fee-based income made up for softer interest income. “Truist delivered strong third-quarter results, underscored by robust fee income growth in investment banking and trading and wealth, healthy loan expansion, and continued expense and credit discipline,” said CEO Bill Rogers in
17 October 2025
··
Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

RIL Q2 Earnings Signal Steady Growth Across Businesses Mumbai, Oct 17, 2025 (News Report): Reliance Industries – India’s largest company by market value – announced its July–September quarter results on Friday, delivering a solid performance amid high investor expectations. Early indications from brokerage estimates suggest double-digit growth in both profit and revenue for Q2 FY2026, driven by strength in RIL’s core businesses. Analysts had widely predicted a “healthy double-digit rise in consolidated revenue and profit” year-on-yearlivemint.com, and RIL appears to have largely met those optimistic forecasts. This comes after an extraordinary Q1 where Reliance booked record profits thanks to a
17 October 2025
··
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Surges on Obesity Drug Boom and Alzheimer’s Breakthroughs – Is $1,000 Next?

LLY Stock Skyrockets, Then Dips on Pricing Jitters Eli Lilly’s stock has been on a tear in 2025, powered by optimism around its new drug innovations. Shares surged dramatically at the start of October – leaping from about $726 at the end of September to as high as $832 by October 1ts2.tech. This double-digit jump in just days far outpaced the broader market and reflected euphoric sentiment toward Lilly’s growth prospectsts2.tech. Analysts attributed the rally to a perfect storm of positive news: strong recent earnings, insider buying, and fresh research fueling excitement about Lilly’s obesity and Alzheimer’s franchisests2.tech. For example,
17 October 2025
·
OpenAI’s AMD Mega-Deal Sparks an AI “Mega-Blob” – 6GW of Chips, a 10% Stake, and a $100B Bet

AMD Stock Surges After AI Mega-Deals With OpenAI and Oracle – Could $300 Be Next?

Stock Hits Highs on AI Hype Advanced Micro Devices’ stock has been on fire in October 2025, reaching its highest levels in over a year. On Wednesday, Oct. 15, AMD surged over 8% and touched an intraday peak around $240.48, a new 52-week hights2.tech. It closed that day near $238.7, capping roughly an 80% year-to-date gain for the chipmaker’s sharests2.tech. By comparison, chief rival Nvidia’s stock is up about 40% in 2025, and Intel’s is flat-to-moderately higher after a rough 2024ts2.tech. AMD’s market capitalization now sits around $350 billion, putting it in the upper echelon of chipmakers by valuets2.tech. This short-term
17 October 2025
··
Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Real-Time Price Check: BAC Slips After Initial Rally After a mid-week surge on earnings, Bank of America’s stock has seesawed amid broader market swings. As of midday Friday (Oct. 17), BAC traded around the $50 mark, down about 1–2% on the dayreuters.com. The stock opened at $50.38 and showed modest volatility through the morningmarketbeat.com. This minor pullback comes on the heels of a sharp drop on Thursday, when BAC plunged 3.5% to close at $50.44finviz.com. That decline essentially wiped out the gains from Wednesday, when shares jumped roughly 4–5% following the earnings announcementreuters.com. The choppy trading reflects a mix of
17 October 2025
·
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir (PLTR) Stock Soars 300% on AI Mega-Deals – Boom or Bubble Ahead?

Red-Hot Rally Fueled by AI Mania Palantir Technologies has seen its stock go parabolic in 2025, transforming from a mid-cap data firm into a near half-trillion-dollar tech titan. Shares of PLTR currently trade around $178–$180 – about 3–4 times their price at the start of the yearts2.tech. This meteoric rise (+300% YTD) vastly outpaces the broader market and has vaulted Palantir into the ranks of the most valuable tech companies. In fact, Palantir’s market value (roughly $425 billion at last count) is now comparable to or larger than legacy defense giants like Lockheed Martin, RTX, and Northrop combinedreuters.com. As tech news
17 October 2025
··
Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Surprise Loan Frauds at Regional Banks Shake Confidence Mid-sized banks shocked Wall Street this week with alarming disclosures of bad loans. Zions Bancorporation – a Utah-based regional lender – stunned investors by announcing a $50 million charge-off tied to two commercial loans that it says were compromised by fraud theguardian.com. In an SEC filing, Zions reported “misrepresentations and contractual defaults” by the borrowers and moved to accelerate the loans to default and sue the guarantors ts2.tech ts2.tech. Western Alliance, a Phoenix-based peer, also revealed it is dealing with a fraudulent borrower, having filed a lawsuit back in August after the client
17 October 2025
Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Rally Stalls at “Uptober” Highs, Then a Healthy Reset October started with a bang for Solana – the coin surged roughly 25% in early “Uptober,” briefly spiking above $250 around Oct. 6 ts2.tech. That marked Solana’s strongest price since January and capped a massive run-up from its 2024 lows. The rally was fueled by broad crypto momentum and anticipation of Solana ETF approvals, along with big institutional buys. By mid-month, however, SOL lost steam. After peaking near $240–$250, it reversed sharply, slipping below $220 and even $200 as traders took profits ts2.tech ts2.tech. As of Oct. 17, Solana hovers in
17 October 2025
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SOFI Stock Price: 2025 Surge and Recent Volatility After a spectacular rally through 2025, SoFi’s share price has been on a roller coaster in recent weeks. The stock more than tripled in the past year, climbing from the single digits to a high of about $30.30 by late September ts2.tech. That ~230% year-over-year gain far outpaced most fintech and bank stocks. However, the euphoria has cooled slightly in October: SoFi pulled back roughly 10% from its peak, trading in the mid-$20s as some investors took profits ts2.tech. The past week highlighted SoFi’s high volatility. Shares briefly rebounded above $28 mid-week,
17 October 2025
·
INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

Stock Price Surge and Aftermath INVO Fertility’s stock took Wall Street by surprise this week with a massive one-day surge. On October 16, shares of the micro-cap fertility clinic operator opened around $0.75 and skyrocketed nearly 90% by day’s end, closing at approximately $1.43 ts2.tech. Intra-day, the price briefly hit $2+ per share, a huge jump from the prior day’s close under $0.80 ts2.tech. To put this in perspective, such a single-day leap is virtually unheard of for most stocks – even in the volatile biotech space – and far outpaced broader market moves. Trading volume spiked astronomically during the
17 October 2025
·
Amazon Stock Today: AI Ambitions, $2.5B Twist, and $3 Trillion Dreams

Amazon Stock Rebound Stalls: AI Ambitions, $2.5B Settlement & the $3 Trillion Question

Stock Price & Recent Performance Amazon.com, Inc. (NASDAQ: AMZN) has seen choppy trading in recent days. The stock fell sharply by about 5% on Oct. 13 amid a broader tech sell-off tied to renewed U.S.–China trade tensionsts2.tech. After closing around $227 last week, shares dipped to the mid-$210s before stabilizing. Over the past week, AMZN oscillated roughly between $216 and $228 – holding above a support level near ~$215 but unable to break through resistance in the mid-$220sts2.tech. Traders noted the stock recently “rebounded off” those support levels as Amazon’s expansion announcements buoyed sentiment, though it remains below key trend
17 October 2025
···
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s Weight-Loss Crown at Risk? NVO Stock Slumps Amid Surprise Deals – What’s Next

NVO Stock Slides as Weight-Loss Hype Cools Novo Nordisk’s stock has been on a wild ride. After becoming Europe’s most valuable company in 2022–2023 on the back of its smash-hit obesity drug Wegovy, the Danish pharma giant has seen its fortunes reverse sharply in 2025. As of October 17, NVO shares trade in the mid-$50s – down nearly 50% from January levelsreuters.comreuters.com and miles below the late-2024 peak (when Novo’s market cap neared $650 B)reuters.comreuters.com. What happened? In short, the once-unbounded GLP-1 weight-loss boom has hit reality. Several factors have converged to deflate Novo’s valuation. Competition has intensified: U.S. rival Eli
17 October 2025
·
Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle’s $300B AI Cloud Bet Sends Stock Soaring – Trillion-Dollar Dreams Awaken

Oracle Stock Update: Riding High on AI Frenzy Oracle headquarters building. Oracle’s stock has been a standout performer in 2025 amid a frenzy for AI-related cloud services. Oracle’s stock price is hovering near $304 per share as of October 17, 2025, after a year of extraordinary gains driven by optimism around the company’s foray into artificial intelligence cloud servicests2.tech. It closed at $303.98 on October 16ts2.tech, essentially flat on the day, capping off a volatile few weeks. Just last month, Oracle shares touched a record intraday high of about $345.69 (on Sept. 10) following announcements of unprecedented AI cloud dealsts2.tech.
17 October 2025
··
Apple’s July 2025 Bombshells: Foldable iPhone, AI Secrets, Encryption Showdown & More

Apple Stock Surges on New Products and iPhone 17 “Supercycle” – Analysts Split on AAPL’s Next Move

AAPL Stock Update: Near Highs After Volatile Week Apple’s stock is trading near record levels as of October 17, 2025, after navigating a volatile stretch in global markets. Shares oscillated around the mid-$240s this week – just a few dollars below Apple’s all-time intraday high (~$260) set in late Septemberts2.tech. On Wednesday Oct. 15, AAPL briefly rallied (+0.6%) on news of Apple’s latest chip launch, before slipping ~0.9% on Thursday amid some profit-takingts2.techts2.tech. As of midday Friday, the stock was little changed, holding above both its 50- and 200-day moving averages – a sign of positive momentum in recent weeksts2.tech.
17 October 2025
·
Nvidia’s $4 Trillion AI Stock Surge: Record Highs, Mega Deals & Bold Forecasts

Nvidia Stock Whipsaws as AI Boom Clashes with New Risks

NVDA Stock Rollercoaster: From Record Highs to Sharp Swings Nvidia’s stock has been on a wild ride in recent days. The share price reached an all-time high of about $195.62 in early Octoberts2.tech amid frenzied buying, but then rapidly reversed course. By Tuesday, Oct. 14, NVDA had tumbled over 4% in a single session to around $180ts2.tech as traders cashed in gains and broader tech stocks slipped. The Nasdaq’s tech sector was down that day, reflecting profit-taking and a rotation out of high-flying names. Even so, Nvidia’s stock remains near its peaks – still roughly 58% higher than a year
17 October 2025
·
AST SpaceMobile (ASTS) Stock Skyrockets on Verizon Deal – Is Satellite-to-Phone Broadband the Next Big Thing?

AST SpaceMobile Stock Shoots for the Stars on Verizon Deal – What’s Next for ASTS?

ASTS Stock Skyrockets on Space Breakthroughs Such meteoric gains have made AST SpaceMobile a market darling of 2025. The company – which went public via SPAC in 2021 – is now valued near $30 billionts2.tech, a staggering figure considering its nascent revenue. Investors have piled into ASTS on the promise that it could revolutionize mobile connectivityts2.techts2.tech. Social media forums show retail traders “extremely bullish” on ASTS, which became a trending ticker on Stocktwits as shares rocketed upwardts2.tech. However, the stock’s volatile swings also hint at speculative fervor: after peaking mid-week, ASTS briefly pulled back by ~6% on profit-takingts2.tech, demonstrating that even
17 October 2025
··
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet (GOOGL) Stock Soars on AI Boom & Ad Rebound – $3 Trillion Valuation in Sight?

GOOGL Stock Nears Record High on Rally Momentum The Google logo at the company’s headquarters. Alphabet’s stock has been flirting with record highs amid surging optimism in its core ads and AI businesses.Alphabet Inc.’s Class A shares (NASDAQ: GOOGL) have been on a tear this year, recently touching their highest levels in over a year. The stock closed at $251.03 on Oct. 16 – around a new 52-week peak of ~$256ts2.tech – after jumping about 2% that day. As of Oct. 17, GOOGL traded just above $251, holding near that high-water mark. At these prices, Alphabet’s market value is roughly $2.97 trillion, putting Google’s
17 October 2025
··
1 … 1,438 1,439 1,440 1,441 1,442 … 1,632

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop